Recombinant Human KLK14 Protein，His

KLK14, also known as kallikrein-related peptidase 14, is a member of the human kallikrein gene family, which plays significant roles in various physiological processes, including tissue remodeling, inflammation, and cancer progression. Research into KLK14 has intensified due to its potential implications in diseases such as breast cancer and other malignancies, where it is often dysregulated. The proteolytic activity of KLK14 facilitates the cleavage of various biomolecules, thereby influencing the tumor microenvironment and metastatic behavior of cancer cells. Advances in recombinant protein technology have enabled the production of active KLK14 for biochemical characterization and therapeutic exploration. Studies have demonstrated that elevated KLK14 levels correlate with poor prognosis and may serve as a novel biomarker for tumor aggressiveness. The investigation of KLK14 as a therapeutic target is particularly appealing, given its specific expression patterns in cancerous tissues compared to normal tissues. Current research focuses on elucidating the substrate specificity of KLK14, understanding its regulatory mechanisms, and exploring its role in the tumorigenic process, which could lead to the development of KLK14-based diagnostic tools and targeted therapies. Overall, the study of KLK14 not only enhances our understanding of kallikrein biology but also opens new avenues for translational research in oncology.